Health protection – collection

Escherichia coli (E. coli): guidance, data and analysis

The characteristics, diagnosis, management, surveillance and epidemiology of Escherichia coli (E. coli).

Escherichia coli (E. coli) bacteria are frequently found in the intestines of humans and animals. There are many different types of E. coli, and while some live in the intestine quite harmlessly, others may cause a variety of diseases.

The bacterium is found in faeces and can survive in the environment. E. coli bacteria can cause a range of infections including urinary tract infection, cystitis (infection of the bladder), and intestinal infection. E. coli bacteraemia (blood stream infection) may be caused by primary infections spreading to the blood.

For guidance on E. coli O157 or VTEC see Vero cytotoxin-producing Escherichia coli (VTEC): guidance, data and analysis.

Diagnosis and management

  1. Urinary Tract Infection (UTI) diagnosis

    • Guidance

Data submission

  1. Escherichia coli bacteraemia: surveillance form

    • Form

Epidemiology

Enhanced surveillance of E. coli bacteraemia has been mandatory for NHS acute trusts since June 2011. Patient data of any E. coli bacteraemias are reported monthly to Public Health England (PHE). Independent sector healthcare organisations providing regulated activities have also undertaken surveillance of E. coli bacteraemia since June 2011.

  1. Escherichia coli (E. coli) bacteraemia: annual data

    • Official Statistics
  2. Escherichia coli (E. coli) bacteraemia: monthly data by NHS acute trust

    • National Statistics
  3. Escherichia coli (E. coli) bacteraemia: monthly data by attributed clinical commissioning group

    • National Statistics
  4. Escherichia coli bacteraemia: annual trends in voluntary surveillance

    • Research and analysis
  5. MRSA, MSSA and E. coli bacteraemia and C. difficile infection: quarterly epidemiological commentary

    • National Statistics
  6. MRSA, MSSA and E. coli bacteraemia and Clostridium difficile infection: annual data for independent sector healthcare organisations

    • Official Statistics
  7. MRSA, MSSA and E. coli bacteraemia and C. difficile infection: annual epidemiological commentary

    • Official Statistics
  8. MRSA, MSSA and E. coli bacteraemia and Clostridium difficile infection: 6-monthly data for independent sector healthcare organisations

    • Official Statistics
  9. MRSA, MSSA and E. coli bacteraemia and C. difficile infection: 30 day all-cause fatality

    • Research and analysis

Official statistics compliance

Healthcare associated infections (HCAI) mandatory surveillance statistics publications are produced in accordance with the code of practice for official statistics and are designated as National Statistics. Below are data-specific documents which describe our compliance with aspects of the Code.

User engagement

Summary of user engagement collates evidence from mandatory HCAI surveillance statistics users. It includes:

  • a summary of how the statistics are used
  • views on how provision of the statistics meets the needs of users
  • our actions in response to user feedback

We will update this document as we receive further user feedback.

Minutes of the HCAI Mandatory Surveillance Stakeholder Engagement Forum:

  1. Pre-release access list: mandatory HCAI statistical releases

    • Guidance
  2. MRSA, MSSA and E. coli bacteraemia and C. difficile infection mandatory data: revisions and amendments policy

    • Guidance
  3. Mandatory healthcare associated infection (HCAI) surveillance: data quality statement

    • Guidance